206 related articles for article (PubMed ID: 34535767)
1. Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming.
Bekhbat M; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
Mol Psychiatry; 2021 Dec; 26(12):7384-7392. PubMed ID: 34535767
[TBL] [Abstract][Full Text] [Related]
2. Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia.
Bekhbat M; Treadway MT; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
Brain Behav Immun; 2020 Aug; 88():161-165. PubMed ID: 32198016
[TBL] [Abstract][Full Text] [Related]
3. Cellular and immunometabolic mechanisms of inflammation in depression: Preliminary findings from single cell RNA sequencing and a tribute to Bruce McEwen.
Bekhbat M; Ulukaya GB; Bhasin MK; Felger JC; Miller AH
Neurobiol Stress; 2022 Jul; 19():100462. PubMed ID: 35655933
[TBL] [Abstract][Full Text] [Related]
4. Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression.
Goldsmith DR; Bekhbat M; Le NA; Chen X; Woolwine BJ; Li Z; Haroon E; Felger JC
Brain Behav Immun; 2020 Aug; 88():193-202. PubMed ID: 32387344
[TBL] [Abstract][Full Text] [Related]
5. Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression.
Bekhbat M; Chu K; Le NA; Woolwine BJ; Haroon E; Miller AH; Felger JC
Psychoneuroendocrinology; 2018 Dec; 98():222-229. PubMed ID: 30249443
[TBL] [Abstract][Full Text] [Related]
6. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
Felger JC; Li Z; Haroon E; Woolwine BJ; Jung MY; Hu X; Miller AH
Mol Psychiatry; 2016 Oct; 21(10):1358-65. PubMed ID: 26552591
[TBL] [Abstract][Full Text] [Related]
7. Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
Haroon E; Fleischer CC; Felger JC; Chen X; Woolwine BJ; Patel T; Hu XP; Miller AH
Mol Psychiatry; 2016 Oct; 21(10):1351-7. PubMed ID: 26754953
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.
Goldsmith DR; Haroon E; Woolwine BJ; Jung MY; Wommack EC; Harvey PD; Treadway MT; Felger JC; Miller AH
Brain Behav Immun; 2016 Aug; 56():281-8. PubMed ID: 27040122
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
Yang C; Bosker FJ; Li J; Schoevers RA
BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Raison CL; Rutherford RE; Woolwine BJ; Shuo C; Schettler P; Drake DF; Haroon E; Miller AH
JAMA Psychiatry; 2013 Jan; 70(1):31-41. PubMed ID: 22945416
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Haroon E; Daguanno AW; Woolwine BJ; Goldsmith DR; Baer WM; Wommack EC; Felger JC; Miller AH
Psychoneuroendocrinology; 2018 Sep; 95():43-49. PubMed ID: 29800779
[TBL] [Abstract][Full Text] [Related]
12. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
Kiraly DD; Horn SR; Van Dam NT; Costi S; Schwartz J; Kim-Schulze S; Patel M; Hodes GE; Russo SJ; Merad M; Iosifescu DV; Charney DS; Murrough JW
Transl Psychiatry; 2017 Mar; 7(3):e1065. PubMed ID: 28323284
[TBL] [Abstract][Full Text] [Related]
13. Internally vs. externally triggered movements in patients with major depression.
Hoffstaedter F; Sarlon J; Grefkes C; Eickhoff SB
Behav Brain Res; 2012 Mar; 228(1):125-32. PubMed ID: 22142951
[TBL] [Abstract][Full Text] [Related]
14. Evidence of an early information processing speed deficit in unipolar major depression.
Tsourtos G; Thompson JC; Stough C
Psychol Med; 2002 Feb; 32(2):259-65. PubMed ID: 11866321
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review.
Yang C; Wardenaar KJ; Bosker FJ; Li J; Schoevers RA
J Affect Disord; 2019 Oct; 257():640-649. PubMed ID: 31357161
[TBL] [Abstract][Full Text] [Related]
16. Motor and cognitive aspects of motor retardation in depression.
Caligiuri MP; Ellwanger J
J Affect Disord; 2000; 57(1-3):83-93. PubMed ID: 10708819
[TBL] [Abstract][Full Text] [Related]
17. Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
Taylor BP; Bruder GE; Stewart JW; McGrath PJ; Halperin J; Ehrlichman H; Quitkin FM
Am J Psychiatry; 2006 Jan; 163(1):73-8. PubMed ID: 16390892
[TBL] [Abstract][Full Text] [Related]
18. What does plasma CRP tell us about peripheral and central inflammation in depression?
Felger JC; Haroon E; Patel TA; Goldsmith DR; Wommack EC; Woolwine BJ; Le NA; Feinberg R; Tansey MG; Miller AH
Mol Psychiatry; 2020 Jun; 25(6):1301-1311. PubMed ID: 29895893
[TBL] [Abstract][Full Text] [Related]
19. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning.
Sánchez-Carro Y; de la Torre-Luque A; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Pérez-Solà V; Toll A; Martínez-Ruiz A; Ferreirós-Martínez R; Pérez S; Sastre J; Álvarez P; Soria V; López-García P
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110674. PubMed ID: 36332700
[TBL] [Abstract][Full Text] [Related]
20. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
